Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...

Pfizer said its experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial. Patients with the ...

Q: Who should I consult if I am suffering from excess weight loss? A: There are many infectious and non-infectious causes that can result in excess weight loss. It is preferable to meet your general ...

Cachexia is common in cancer, yet it is poorly understood in noncancer diagnoses. In this article, Carlson and Dahlin review cancer cachexia in cardiac disease. The definition, pathophysiology, and ...

"With regard to the prospects for treatment of cachexia, the results of the genetic and preclinical models were highly promising. We expect these results to encourage researchers to test the clinical ...

THE striking degree of malnutrition that may accompany chronic congestive heart failure has been termed cardiac cachexia. Hippocrates was perhaps the first to record this association between dropsy ...

Rheumatoid cachexia, or muscle wasting, is a common complication of rheumatoid arthritis (RA) that can lead to fatigue, pain, and even a shorter life expectancy if left unmanaged. While the exact ...